| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/11/2006 | US7074411 α-β C4BP-type recombinant heteromultimeric proteins |
| 07/11/2006 | US7074408 Use of integrin antagonists to inhibit angiogenesis |
| 07/11/2006 | US7074401 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 07/11/2006 | CA2277983C Tyrosine phosphorylated cleavage furrow-associated proteins (pstpips) |
| 07/11/2006 | CA2176463C Hu-b1.219, a novel human hematopoietin receptor |
| 07/11/2006 | CA2117536C Immunological detection of organophosphates |
| 07/06/2006 | WO2006072078A2 Bioproduction of astaxanthin using mutant carotenoid ketolase and cartonenoid hydroxylase genes |
| 07/06/2006 | WO2006072065A2 Pcv2 immunogenic compositions and methods of producing such compositions |
| 07/06/2006 | WO2006071949A2 Zebrafish heterotrimer g-protein gamma 2 subunit (gng2) |
| 07/06/2006 | WO2006070776A1 Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody |
| 07/06/2006 | WO2006070040A1 Protein extracts with a wide range of antibacterial activity and strains of the genus bifidobacterium which produce same |
| 07/06/2006 | WO2006069505A1 The complex granule of hepatitis b surface antigen containing front surface antigen s1 , s2 and s immune determinants. |
| 07/06/2006 | WO2006031689A3 Multimeric constructs |
| 07/06/2006 | WO2006014802A3 Canis sphingosine 1-phosphate receptor isoform 1 |
| 07/06/2006 | WO2005116234A3 Detection and quantification of intracellular pathogens |
| 07/06/2006 | WO2005116072A3 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 07/06/2006 | WO2005082077A3 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 07/06/2006 | WO2005003326A3 Artificial receptors including reversibly immobilized building blocks and methods |
| 07/06/2006 | WO2005003313A8 Methods and compositions for enhanced protein expression and purification |
| 07/06/2006 | WO2004061079A3 Candida kefyr cytosine deaminase |
| 07/06/2006 | US20060150262 Novel mucin-like polypeptides |
| 07/06/2006 | US20060149482 Nucleic acids and proteins with thioredoxin reductase activity |
| 07/06/2006 | US20060149050 Isolation and method of using tissue growth-inducing Frzb |
| 07/06/2006 | US20060149048 Comprises nucleotide sequences coding prostaglandin h synthase for treatment of inflammation; antiinflammatory agents; cytoprotective agents |
| 07/06/2006 | US20060148717 Biocidal proteins |
| 07/06/2006 | US20060148709 Neuroprotective properties of GDF-15, a novel member of the TGF-Beta superfamily |
| 07/06/2006 | US20060148708 C5a receptor |
| 07/06/2006 | US20060148705 Nucleic acids; fusion proteins; binding to endothelial growth factor; fusion polypeptides capable of binding vascular endothelial cell growth factor (VEGF), VEGF family members, and splice variants with specifically desirable characteristics; therapy for ocular diseases |
| 07/06/2006 | US20060148692 Novel protein and its dna |
| 07/06/2006 | US20060148690 Secreted peptides |
| 07/06/2006 | US20060148689 A peptide consisting of a sequence comprising a tripeptide and tetrapeptide linked or existing separately with specific recognition of lipid vectors, particularly negativelycharged phosphatides on cell surfaces; stability; labels;fluorescence; imaging contrast agents; kitsanalyzing; diagnosis/medical |
| 07/06/2006 | US20060148680 Glycoproteins produced in plants and methods of their use |
| 07/06/2006 | US20060148085 High yield heterologous expression cell lines for expression of gene products with human glycosylation pattern |
| 07/06/2006 | US20060148074 Serum-free mammalian cell culture medium, and uses thereof |
| 07/06/2006 | US20060148061 Protein having L-rhamnose isomerise activity, used to catalyze the production of a rare sugar, D-allose, from D-psicose and a DNA encoding it |
| 07/06/2006 | US20060148060 Biomolecule transduction motif Mph-1-BTM and the use thereof |
| 07/06/2006 | US20060148056 Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 07/06/2006 | US20060148054 Enzymes for starch processing |
| 07/06/2006 | US20060148053 Process for the biological production of 1,3-propanediol with high titer |
| 07/06/2006 | US20060148039 Methylotroph producing mammalian type sugar chain |
| 07/06/2006 | US20060148038 Thrombin cleavable factor x analogues |
| 07/06/2006 | US20060148037 amino acid sequence is encoded by nucleotide sequences, a potassium channel modulators; cell producing a membrane protein associated with ionic mobility for detecting and preventing pancreatic disorders; diagnose diabetes; producing biodrug for treating type 1 and type 2 diabetes |
| 07/06/2006 | US20060148036 GABAalpha receptor epsilon subunits |
| 07/06/2006 | US20060148035 Host cells containing mannosidase catalytic domains within endoplasmic reticulum or Golgi complex for producing glycoproteins with glycan structures attached in glycoform that serve as substrate for transferases |
| 07/06/2006 | US20060148034 Exposing shrimp to aqueous solution of trichoanguin protein |
| 07/06/2006 | US20060148033 A vector having a portion encoding a 5'-untranslated region from an mRNA for a cold shock protein gene that has a mutation that changes the distance of the stem structure formed by the region; used for genetic engineering |
| 07/06/2006 | US20060148032 Novel phosphoprotein |
| 07/06/2006 | US20060148031 Hemipteran myosin light chain kinase |
| 07/06/2006 | US20060148030 Nuclear receptor err y 3 |
| 07/06/2006 | US20060148029 Lactoferricin gene and transformant expressing lactoferricin |
| 07/06/2006 | US20060148026 Engineering redox proteins |
| 07/06/2006 | US20060148018 Insulin-like growth factor binding protein-4 protease |
| 07/06/2006 | US20060148011 Diagnosing prostate cancer by contacting a biological fluid sample (plasma) or prostatic tissue specimen from the subject with an antibody which binds to SEQ ID NO: 1, detecting binding of the antibody in the specimen and correlating the detected binding to prostate cancer |
| 07/06/2006 | US20060148005 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 07/06/2006 | US20060147990 Using polymerase chain reaction to amplify preferential DNA sequences for use directed translation events |
| 07/06/2006 | US20060147989 administering to mammals mixtures of plant extracts from ginger, green tea, turmeric, horseradish and carriers |
| 07/06/2006 | US20060147988 Vertebrate transmembrane protein (UNC-5 protein) for use in diagnosis, prevention and treatment of nervous system disorders |
| 07/06/2006 | US20060147982 32 human secreted proteins |
| 07/06/2006 | US20060147980 Methods for isolating and characterizing endogenous mRNA-protein (mRNP) complexes |
| 07/06/2006 | US20060147974 Novel Drosophila tumor necrosis factor class molecule ("DmTNF") and variants thereof |
| 07/06/2006 | US20060147973 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 07/06/2006 | US20060147967 high processivity and strand-displacement activity |
| 07/06/2006 | US20060147951 "STRAP" and "STEAP" (six transmembrane epithelial antigen of the prostate) |
| 07/06/2006 | US20060147950 Precursor conversion screening method |
| 07/06/2006 | US20060147946 Novel calcium channel variants and methods of use thereof |
| 07/06/2006 | US20060147945 Novel secreted proteins and their uses |
| 07/06/2006 | US20060147923 Nucleic acid sequences encoding novel point mutations on mglur2 and mglur3 |
| 07/06/2006 | US20060147914 evaluating ability of agents to modulate Homer protein activity, Homer protein/immunophilin-peptidylproline cis-trans isomerase interaction, and/or Homer protein/proline-type Homer ligand consensus sequence interaction to identify agents for treatment; modulation of immunosupression and neuroprotection |
| 07/06/2006 | US20060147910 Detection of mutations |
| 07/06/2006 | US20060147908 "Prionins", highly specific markers for noninvasive presymptomatic detection of TSE diseases, and targets for therapeutic reagents to prevent and control TSE diseases in animals and humans. |
| 07/06/2006 | US20060147581 Hybrid enzymes |
| 07/06/2006 | US20060147499 Proteases |
| 07/06/2006 | US20060147478 Protein involved in carcinoma |
| 07/06/2006 | US20060147477 Immunogenic compositions |
| 07/06/2006 | US20060147475 Ringworm vaccine |
| 07/06/2006 | US20060147474 Detection of antibodies against chamydia trachomatis PGP3 antigen in patient sera by enzyme-linked immunoassay |
| 07/06/2006 | US20060147467 Materials and methods for immunizing against FIV infection |
| 07/06/2006 | US20060147462 For diagnostic, prophylactic and therapeutic uses, vaccines against bacterial infections |
| 07/06/2006 | US20060147461 Use of ClyA hemolysin for excretion of proteins |
| 07/06/2006 | US20060147458 Vaccines |
| 07/06/2006 | US20060147454 Human serine protease and serpin polypeptides |
| 07/06/2006 | US20060147452 Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same |
| 07/06/2006 | US20060147450 Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists |
| 07/06/2006 | US20060147449 Method of using CD100 (or Sema4D) to mediate platelet activation and inflammatory responses |
| 07/06/2006 | US20060147445 Immunoglobulin DNA cassette molecules, monobody constructs, methods of production, and methods of use therefor |
| 07/06/2006 | US20060147444 Biosynthetic binding proteins for immuno-targeting |
| 07/06/2006 | US20060147437 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/06/2006 | US20060147421 Methods and compositions for treating and preventing infection using human interferon regulatory factor 3 |
| 07/06/2006 | US20060147375 Antibodies and related molecules that bind to PSCA proteins |
| 07/06/2006 | US20060147373 Compositions and methods for the diagnosis and treatment of tumor |
| 07/06/2006 | CA2594289A1 Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody |
| 07/05/2006 | EP1676924A1 Cyclic GMP dependent protein kinase of toxoplasma gondii as a chemotherapeutic target for antiprotozoal agents |
| 07/05/2006 | EP1676918A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 07/05/2006 | EP1676912A2 Medical equipment containing a polypeptide having heparanase activity |
| 07/05/2006 | EP1676911A1 Novel recombinant animal cells with high protein production, method of constructing the same and method of mass protein production using the same |
| 07/05/2006 | EP1676910A1 Genomically modified cell |
| 07/05/2006 | EP1676862A1 Recombinant antibody against human insulin-like growth factor |
| 07/05/2006 | EP1676860A1 Process for producing antithrombin iii composition |
| 07/05/2006 | EP1676857A2 Receptor that binds trail |
| 07/05/2006 | EP1676587A1 Pharmaceutical compositions for therapeutic use |